Rockefeller Capital Management L.P. Guardant Health, Inc. Transaction History

Rockefeller Capital Management L.P.

$36.3 Billion
Q3 2024

A detailed history of Rockefeller Capital Management L.P. transactions in Guardant Health, Inc. stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 13,600 shares of GH stock, worth $498,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,600

Previous 17,061 20.29%

Holding current value

$498,575

Previous $492,000 36.79%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$22.3 - $36.29 $77,180 - $125,599	-3,461 Reduced 20.29%	13,600 $311,000
Q2 2024 Aug 12, 2024	SELL	$16.07 - $31.84 $132,448 - $262,425	-8,242 Reduced 32.57%	17,061 $492,000
Q1 2024 May 14, 2024	BUY	$17.13 - $26.91 $99,525 - $156,347	5,810 Added 29.81%	25,303 $522,000
Q4 2023 Feb 14, 2024	SELL	$21.58 - $29.5 $17,997 - $24,603	-834 Reduced 4.1%	19,493 $527,000
Q3 2023 Nov 14, 2023	SELL	$25.8 - $39.97 $317,830 - $492,390	-12,319 Reduced 37.74%	20,327 $602,000
Q2 2023 Aug 14, 2023	SELL	$20.94 - $38.01 $62 - $114	-3 Reduced 0.01%	32,646 $1.17 Million
Q1 2023 May 17, 2023	SELL	$22.92 - $33.76 $155,420 - $228,926	-6,781 Reduced 17.2%	32,649 $765,000
Q4 2022 Mar 06, 2023	BUY	$25.44 - $59.78 $168,565 - $396,102	6,626 Added 20.2%	39,430 $1.07 Million
Q3 2022 Nov 02, 2022	BUY	$43.66 - $61.0 $84,438 - $117,974	1,934 Added 6.26%	32,804 $1.76 Million
Q2 2022 Aug 12, 2022	BUY	$28.82 - $77.35 $226,150 - $606,965	7,847 Added 34.08%	30,870 $1.24 Million
Q1 2022 May 13, 2022	SELL	$48.25 - $100.49 $14,475 - $30,147	-300 Reduced 1.29%	23,023 $1.52 Million
Q4 2021 Feb 14, 2022	BUY	$88.71 - $120.43 $734,696 - $997,401	8,282 Added 55.06%	23,323 $2.33 Million
Q3 2021 Nov 12, 2021	BUY	$98.77 - $132.17 $268,555 - $359,370	2,719 Added 22.07%	15,041 $1.88 Million
Q2 2021 Aug 10, 2021	BUY	$109.77 - $165.68 $227,333 - $343,123	2,071 Added 20.2%	12,322 $1.53 Million
Q1 2021 May 11, 2021	SELL	$127.04 - $179.1 $51,070 - $71,998	-402 Reduced 3.77%	10,251 $1.56 Million
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $70,071 - $95,286	701 Added 7.04%	10,653 $1.37 Million
Q3 2020 Nov 13, 2020	BUY	$80.32 - $111.8 $290,437 - $404,268	3,616 Added 57.07%	9,952 $1.11 Million
Q2 2020 Aug 12, 2020	BUY	$60.49 - $97.5 $62,607 - $100,912	1,035 Added 19.52%	6,336 $514,000
Q1 2020 May 12, 2020	BUY	$59.04 - $88.81 $203,038 - $305,417	3,439 Added 184.69%	5,301 $369,000
Q4 2019 Feb 07, 2020	BUY	$59.49 - $82.78 $1,546 - $2,152	26 Added 1.42%	1,862 $146,000
Q3 2019 Nov 12, 2019	SELL	$62.59 - $110.3 $2,628 - $4,632	-42 Reduced 2.24%	1,836 $117,000
Q2 2019 Aug 09, 2019	BUY	$63.94 - $91.11 $120,079 - $171,104	1,878 New	1,878 $162,000

Others Institutions Holding GH

# of Institutions

325

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.75B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.

Account

Rockefeller Capital Management L.P. Guardant Health, Inc. Transaction History